WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Empagliflozin (Jardiance, Glyxambi, Synjardy, Trijardy) in Iowa

Also known as: Jardiance, Glyxambi, Synjardy, Trijardy

Find doctors, physicians, and healthcare providers who prescribe Empagliflozin in Iowa. This page lists the top prescribers of Empagliflozin based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Empagliflozin?

SYNJARDY SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an additional treatment to diet and exercise to improve glycemic control in adults and children aged 10 years and older with type 2 diabetes. It belongs to a class of drugs known as sodium-glucose cotransporter 2 inhibitor.

Total Claims in Iowa
78,294
1.0% of all Empagliflozin prescriptions nationwide
Total Beneficiaries in Iowa
11,272
Total Cost in Iowa
$76,662,429

Top Prescribers in IA(2+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Richard CaranoAmes, IAEndocrinology755137$795,987
Mark JohnsonMason City, IAEndocrinology705114$600,046
Loading more data in background...

Find Empagliflozin doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.